Drug Information for LOXITANE (Loxapine Succinate) Capsules Revised: March 2008 14750-1 Rx only (Watson Pharma, Inc.): HOW SUPPLIED

Ads
  • LOXITANE®, loxapine succinate capsules, are available in the following strengths:

    Loxapine Succinate 6.8 mg equivalent to 5 mg loxapine, hard shell, opaque, dark green capsules printed with “” over “WATSON” on one half and “LOXITANE” over “5 mg” on the other, are supplied as follows:

    NDC 52544-494-01 - Bottle of 100sNDC 52544-494-10 - Bottle of 1000s

    Loxapine Succinate 13.6 mg equivalent to 10 mg loxapine, hard shell, opaque, with yellow body and a dark green cap, printed with “” over “WATSON” on one half and “LOXITANE” over “10 mg” on the other, are supplied as follows:

    NDC 52544-495-01 - Bottle of 100sNDC 52544-495-10 - Bottle of 1000s

    Loxapine Succinate 34.0 mg equivalent to 25 mg loxapine, hard shell, opaque, with a light-green body and a dark green cap, printed with “” over “WATSON” on one half and “LOXITANE” over “25 mg” on the other, are supplied as follows:

    NDC 52544-496-01 - Bottle of 100sNDC 52544-496-10 - Bottle of 1000s

    Loxapine Succinate 68.1 mg equivalent to 50 mg loxapine, hard shell, opaque, with a blue body and a dark green cap, printed with “” over “WATSON” on one half and “LOXITANE” over “50 mg” on the other, are supplied as follows:

    NDC 52544-497-01 - Bottle of 100sNDC 52544-497-10 - Bottle of 1000s

    Store at 20°-25°C (68°-77°F). [See USP controlled room temperature.] Dispense in a tight, child-resistant container.

    Manufactured by:Watson Laboratories, Inc.Corona, CA 92880 USA

    Distributed by:Watson Pharma, Inc.

    Revised: March 200814750-10308B

  • Drug Information Provided by National Library of Medicine (NLM).
Ads